Literature DB >> 16935862

A case of metastatic testicular cancer complicated by tumour lysis syndrome and choriocarcinoma syndrome.

Koji Kawai1, Ei-Ichiro Takaoka, Makito Naoi, Kensaku Mori, Manabu Minami, Toru Shimazui, Hideyuki Akaza.   

Abstract

A 26-year-old man was referred to our hospital for treatment of metastatic testicular cancer. The pathological diagnosis was choriocarcinoma with seminoma. Sequential computerized tomography examinations revealed rapidly progressing bulky liver metastases and a lung metastasis. Chemotherapy with bleomycin, etoposide and cisplatin (BEP) was started on the day of admission. Subsequently, the patient suffered from tumour lysis syndrome (TLS) and massive haemorrhage at metastatic sites. The latter complication is also called choriocarcinoma syndrome. To our knowledge, this is the first case report of testicular cancer complicated with both critical conditions. Intensive care and radiological intervention barely prevented a fatal outcome. The urological oncologist should be aware of the potential complications TLS and choriocarcinoma syndrome in cases of rapidly progressive and high-volume choriocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935862     DOI: 10.1093/jjco/hyl078

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  12 in total

Review 1.  Testicular choriocarcinoma: a rare variant that requires a unique treatment approach.

Authors:  Matthew James Reilley; Lance C Pagliaro
Journal:  Curr Oncol Rep       Date:  2015-02       Impact factor: 5.075

2.  A case of gastrointestinal bleeding due to duodenal metastasis from a testicular choriocarcinoma.

Authors:  Magdalene Vardaros; Miral Subhani; Kaleem Rizvon; Vladimir Gotlieb; Paul Mustacchia; Lester Freedman; Vikas Garg; Jaspreet Singh; Ghulam Siddiqui
Journal:  J Gastrointest Cancer       Date:  2013-06

3.  Bleomycin-induced pulmonary fibrosis after tumor lysis syndrome in a case of advanced yolk sac tumor treated with bleomycin, etoposide and cisplatin (BEP) chemotherapy.

Authors:  Mihoko Doi; Yohei Okamoto; Masami Yamauchi; Hiroyuki Naitou; Katsunori Shinozaki
Journal:  Int J Clin Oncol       Date:  2011-11-30       Impact factor: 3.402

4.  Advanced testicular cancer associated with life-threatening tumour lysis syndrome and choriocarcinoma syndrome.

Authors:  Kohei Kobatake; Masao Kato; Koji Mita
Journal:  Can Urol Assoc J       Date:  2015 Jan-Feb       Impact factor: 1.862

5.  Choriocarcinoma syndrome in a 24-year-old male.

Authors:  Santiago Arana; Mariano Fielli; Alejandra González; Jaime Segovia; Marcelo Villaverde
Journal:  JRSM Short Rep       Date:  2012-06-28

6.  Tumour lysis syndrome: A rare acute presentation of locally advanced testicular cancer - Case report and review of literature.

Authors:  Marcus Chow; Arianto Yuwono; Ronny Tan
Journal:  Asian J Urol       Date:  2015-10-24

7.  Choriocarcinoma Syndrome as an Initial Presentation of Testicular Cancer.

Authors:  Carlos Eduardo Salazar-Mejía; María Elena García-Gutiérrez; María Inés Contreras-Salcido; Carlos Javier Rodríguez-Álvarez; Blanca Otilia Wimer-Castillo; Jackeline Grace Lara-Campos; Edio Llerena-Hernández; José Luis González-Vela; David Hernández-Barajas
Journal:  Case Rep Oncol Med       Date:  2018-11-08

8.  Successful treatment of multisite hemorrhage by several methods in brain metastasis of choriocarcinoma: A case report.

Authors:  Zhen Ren; Li Yu; Mengnv Xie; Yiyi Liang; Fang Zhu; Rui Huang; Zhibang Zhang; Chun Fu
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

9.  An Exceptionally Rare Cause of Refractory Gastrointestinal Bleed: Choriocarcinoma Syndrome.

Authors:  Jennifer Yoon; Steve Hu; Jessica Farrell; Kandarp K Shah; Jaya Krishna Chintanaboina
Journal:  Cureus       Date:  2021-04-20

10.  Metastatic testicular cancer presenting with liver and kidney dysfunction treated with modified BEP chemotherapy combined with continuous hemodiafiltration and rasburicase.

Authors:  Mai Kimakura; Toyofumi Abe; Akira Nagahara; Kazutoshi Fujita; Hiroshi Kiuchi; Motohide Uemura; Norio Nonomura
Journal:  Anticancer Drugs       Date:  2016-04       Impact factor: 2.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.